Free tool
Healthcare stocks
We cover 51 companies in the Healthcare sector. The median market value in the group is $4.40B. Across the group, the median move over the past trading day is +0.90%. 72% of the 50 with a 200-day average trade above it. Price change over the past year runs from −19.1% to +59.7% across the middle 80 percent of the group, with a median of +5.1%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
51 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| RHO.DE | Roche Holding AG | 405.40 EUR | +2.01% | +14.00% | +41.42% |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% |
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% |
| NVO.WA | Novo Nordisk A/S | 175.12 PLN | −10.34% | −1.45% | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% |
| DEMANT.CO | Demant A/S | 284.60 DKK | +0.21% | +33.36% | +17.12% |
| WDH1.DE | Demant A/S | 39.10 EUR | +2.84% | +36.62% | −5.53% |
| KRK.WA | Krka, d. d. | 1,110.00 PLN | −2.63% | +29.07% | +30.59% |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% |
| ALK-B.CO | ALK-Abelló A/S | 208.80 DKK | −6.62% | −7.16% | +5.09% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| HLUN-B.CO | H. Lundbeck A/S | 42.68 DKK | +1.19% | +2.35% | +8.99% |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% |
| CTEC.L | Convatec Group PLC | 228.80 GBP | −0.78% | −4.49% | −1.95% |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% |
| HIK.L | Hikma Pharmaceuticals PLC | 1,640.00 GBP | +0.61% | +7.71% | −9.62% |
| OBCK.DE | Ottobock SE & Co. KGaA | 60.40 EUR | +4.50% | +0.68% | +0.68% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | 23.00 EUR | +3.84% | +58.22% | +1.26% |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% |
| FIE.DE | Fielmann Group AG | 39.25 EUR | −5.08% | −10.08% | −27.31% |
| 22Z.DE | Zealand Pharma A/S | 43.35 EUR | +7.70% | −29.74% | −28.16% |
| ZEAL.CO | Zealand Pharma A/S | 326.90 DKK | +7.15% | −28.95% | −25.94% |
| VIRP.PA | Virbac SA | 329.00 EUR | −5.32% | −6.93% | −2.08% |
| AFX.DE | Carl Zeiss Meditec AG | 31.92 EUR | +6.33% | −17.62% | −24.83% |
| BIOA-B.ST | BioArctic AB (publ) | 345.00 SEK | +6.35% | +11.66% | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | 74.70 SEK | −7.15% | −8.74% | −24.65% |
| B72.DE | AtaiBeckley Inc. | 6.45 EUR | +2.38% | +88.27% | +59.69% |
| AMBU-B.CO | Ambu A/S | 78.40 DKK | +8.59% | −9.10% | −19.13% |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% |
| EMEIS.PA | emeis Société anonyme | 13.80 EUR | −0.86% | −5.61% | +10.93% |
| BAVA.CO | Bavarian Nordic A/S | 218.20 DKK | +23.42% | +13.17% | −7.97% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% |
| ONT.L | Oxford Nanopore Technologies plc | 183.00 GBP | +62.81% | +42.97% | −2.24% |
| DMP.DE | Dermapharm Holding SE | 42.00 EUR | −1.98% | +8.95% | +27.27% |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% |
| HCM.L | HUTCHMED (China) Limited | 179.00 GBP | +3.17% | −12.25% | −18.08% |
| GN.CO | GN Store Nord A/S | 94.54 DKK | −2.03% | −13.98% | −18.50% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.